The members of the organizing committee of the 3rd Therapeutic Discoveries Symposium are leading scientists, health providers, business professionals and humanitarians who have come together from around the world to organize this symposium. Our objective is to show how the global scientific and technological community worked together to combat the pandemic and to uncover lessons learned from the COVID-19 pandemic that will help us prepare for future pandemics and help us treat other diseases

• To bring together the world experts on Academic Drug Discovery to discuss and propose new approaches to discover and develop new therapies.
• To review the scientific discoveries that led to the speedy development of novel and efficacious vaccines and diagnosis tools.
• To discuss how the open science created a world collaboration platform that benefited a rapid understanding of the virus-infection biology.

The Symposium aims to be the hub for the leading Vaccine Development and Therapeutics Discoveries scientists, regulators, developers and distributors to conclude on the best approaches and the appropriate path to follow in combating future pandemics and diseases.

Scientists and researchers who wish to stay abreast on the national and international initiatives affecting the development of safe and effective pharmaceutical drug products.

SCIENTIFIC THEMES TO BE ADDRESSED

 

COVID19: The New Era of Innovative Therapies and Vaccines; Lessons Learned

          

mRNA Based Therapies and Vaccines for Cancer and Rare Diseases

            

Immunotherapies for non-infectious diseases

          

Drug Resistance: Repurposing and Combination Therapies

          

Cell and Gene Therapies

           

AI Accelerating Drug Target, Antigens, and Disease Pathway Discovery

          

Research Funding and Regulatory Issues

           

 We will show how the Global scientific, technological and regulatory collaboration for therapeutics and vaccine discoveries and development can come together to combat diseases based on the lessons learned from COVID-19.